US Federal 2025-2026 Regular Session

US Federal Senate Bill SB3474

Introduced
 
Introduced
12/15/25  

Caption

Cannabinoid Safety and Regulation Act

Impact

One of the primary impacts of SB3474 is the establishment of a federal regulatory framework for cannabinoid products, which may have significant implications for state laws and local regulations. The bill empowers states to implement their own strict regulations on cannabinoid products, but it also prevents them from enacting laws that diverge from the federal standards established under this act. As a result, this could lead to a more uniform regulation of cannabinoid products, impacting everything from health risk protocols to manufacturing processes.

Summary

SB3474, known as the Cannabinoid Safety and Regulation Act, aims to establish comprehensive standards and regulations for cannabinoid products within the United States. The bill requires the Secretary to adopt cannabinoid product standards, which will include ingredient requirements, testing procedures, and labeling guidelines aimed at ensuring public safety. The legislation reflects increasing interest in the safety of cannabinoid products and is designed to mitigate risks associated with their use and distribution.

Contention

Notably, the bill addresses the issue of cannabis-impaired driving, mandating education campaigns and grant programs to support state initiatives aimed at reducing impaired driving incidents. While proponents argue that these measures are crucial for public safety and youth protection, critics may raise concerns about the adequacy of available resources and the effectiveness of educational initiatives—especially among vulnerable populations. Additionally, the bill outlines penalties for violation of standards, sparking discussions on the balance between effective regulation and punitive measures that could adversely affect small businesses in this industry.

Companion Bills

No companion bills found.

Previously Filed As

US SB3206

Relating To Cannabinoids.

US AB8

Cannabis: cannabinoids: industrial hemp.

US SB00970

An Act Concerning Cannabinoids, Hemp And Hemp Products.

US AB2250

Cannabis: cannabinoids.

US SB682

Regulating hemp-derived cannabinoid products.

US AB747

Regulating hemp-derived cannabinoid products.

US S2537

Requires registration and regulation of certain hemp-derived cannabinoids manufactured and sold in this State.

US A4082

Requires registration and regulation of certain hemp-derived cannabinoids manufactured and sold in this State.

US S0137

Hemp-Derived Cannabinoids

US HB1763

Relating to repealing certain offenses and removing certain regulations relating to marihuana, cannabis, cannabinoids, synthetic cannabinoids, and paraphernalia.

Similar Bills

OR SB1548

Relating to marijuana; prescribing an effective date.

UT HB0469

Cannabinoid Amendments

UT HB0054

Cannabinoid Amendments

SC S0137

Hemp-Derived Cannabinoids

SC H3601

Hemp Derived Canabis

AL SB255

Cannabinoid products from hemp; sale regulated by Revenue Department, licensure required; tax imposed

PA HB2309

In preliminary provisions, further providing for definitions; in Pennsylvania Liquor Control Board, further provid ing for general powers of board, for restrictions on members of the board and certain employees of Commonwealth, for enforcement and for biennial reports; in licenses and regulations, liquor, alcohol and malt and brewed beverages, further providing for malt and brewed beverages manufacturers', distributors' and importing distributors' licenses, for number and kinds of licenses allowed same licensee, for responsible alcohol management, for surrender of restaurant, eating place retail dispenser, hotel, club, catering club, importing distributor and distributor license for benefit of licensee, for unlawful acts relative to malt or brewed beverages and licensees and for liability of licensees; providing for hemp-derived cannabinoid beverages; establishing the Local Hemp Sharing Fund; and imposing penalties.

NJ S2537

Requires registration and regulation of certain hemp-derived cannabinoids manufactured and sold in this State.